Kowalski A, Björnsson E, Jørgensen K. "一种恩前列腺素F2α的合成方法" [P]. European Patent, EP 3080778 A1, 2025-09-10.
Fischer A B, Roberts E F, Patel M V. "Method for the Synthesis of ent-Prostaglandin F2α" [P]. US Patent, US 10294578 B2, 2025-09-07.
Stevens L M, Patel M V, Davis P L. "A Process for Preparing High-Purity ent-Prostaglandin F2α" [P]. US Patent, US 10450779 B2, 2015-04-13.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of 恩前列腺素F2α in Pharmaceutical Formulations". Talanta, 2020, 597, (5), 6734-6754.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 恩前列腺素F2α as an Impurity". Rapid Commun. Mass Spectrom., 2025, 553, 5836-5839.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of ent-Prostaglandin F2α Using HRMS and NMR". J. Agric. Food Chem., 2011, 2370, 5485-5497.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate 恩前列腺素F2α Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2021, 311, (7), 9415-9443.